January 31, 2017
Lilly’s Q4 net income up 61%
Driven by new products, including Trulicity, Cyramza, Jardiance and Taltz, Lilly’s volume-driven significant growth in 2016.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: results
January 25, 2017
Novartis 2016 full year net income down 6%
Novartis delivered a solid performance in 2016, absorbing Gleevec US loss of exclusivity while investing in key launches and the Alcon Division turnaround
November 10, 2016
Comprehensive loss for Probiodrug in the third quarter of 2016
Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing therapeutic solutions to treat Alzheimer’s disease, has finished the third quarter 2016…
November 8, 2016
GENFIT's revenue halves in Q3 2016
GENFIT has today announced its cash and cash equivalents as at September 30, 2016
November 8, 2016
Esperite's revenue slightly lifted in Q3 compared to same period last year
The Ducth pharmaceutical company Esperite N.V. has announced today that cumulative consolidated revenue increased
January 29, 2016
Roche annual profit disappoints, outlook muted
Cancer drug maker Roche followed Swiss rival Novartis in disappointing shareholders with a muted forecast for the year, sending its shares lower on Thursday.
September 29, 2015
Allergan expects revenue greater than $8B
Allergan plc has updated its second-half 2015 continuing operations financial forecast. The forecast reflects adjustments for the upcoming expected discontinued operations